Distinct epigenetic profiling in head and neck squamous cell carcinoma stem cells

Area of Science:

• Epigenetics
• Cancer Biology
• Oncology

Background:

• Head and neck squamous cell carcinoma (HNSCC) is a significant cause of cancer-related mortality.
• Cancer stem cells (CSCs) are implicated in tumor recurrence and therapeutic resistance in HNSCC.
• Identifying unique CSC characteristics is crucial for developing effective HNSCC treatments.

Purpose of the Study:

• To elucidate the unique epigenetic signature of cancer stem cells (CSCs) within head and neck squamous cell carcinoma (HNSCC).
• To identify specific genes that are differentially methylated in HNSCC CSCs compared to non-stem cancer cells.
• To explore the potential of these epigenetic markers as therapeutic targets for HNSCC.

Main Methods:

• Isolation of HNSCC CSCs (CD44hi) and non-stem cells (CD44low) using CD44 staining and flow cytometry.
• Characterization of stemness gene expression and chemosensitivity in isolated cell populations.
• High-throughput epigenetic profiling via Illumina BeadChip Array, analyzing 28,544 CpG sites across 14,956 genes.

Main Results:

• CD44hi CSCs exhibited higher stemness marker expression and greater resistance to chemotherapy than CD44low non-SCs.
• DNA methylation microarray identified 17 hypomethylated and 9 hypermethylated genes in CD44hi CSCs versus CD44low non-SCs.
• Cluster analysis confirmed distinct epigenetic profiles between CD44hi CSCs and CD44low non-SCs in all tested HNSCC cell lines.

Conclusions:

• HNSCC CSCs possess a unique epigenetic profile characterized by specific methylation patterns.
• The identified 26 differentially methylated genes are potentially critical for maintaining CSC stemness and pluripotency.
• These epigenetically distinct genes represent promising novel molecular targets for eradicating CSCs in HNSCC therapy.